Veracyte is a pioneering genomic diagnostics company. Our tests provide trustworthy and actionable ANSWERS that improve patient care when diagnostic test results are uncertain.
We ask the right questions and provide answers that give physicians and patients a clearer path forward.

Our tests leverage innovations in genomic technology and machine learning to enable a significantly more confident diagnosis than currently possible in challenging diseases such as thyroid cancer, lung cancer and idiopathic pulmonary fibrosis. We are creating new standards of care in the diagnosis of these diseases by enabling more patients to avoid unnecessary invasive procedures, speeding time to diagnosis and removing costs from the healthcare system.

We are changing today's clinical practice standards. We are making a difference in the lives of physicians and patients. We are doing something real.
Our Mission
To improve the lives of patients by resolving diagnostic uncertainty and reducing
risky, costly and often unnecessary surgeries.

Our Vision
To lead a transformation of diagnostics with a new genomic standard of truth.